Table 3.

Summary of Adverse Events Caused by Tumor Necrosis Factor-α Inhibitors

Summary	Infliximab (n=83)	Adalimumab (n=30)	p-value
Any adverse event	12 (14.5)	2 (6.7)	0.441
Acute infusion/injection reaction	7 (7.5)	1 (3.3)
Headache	1 (1.2)	0
Dizziness	1 (1.2)	0
Urticaria	3 (3.6)	1 (3.3)

Data are presented as number (%).